BioCentury | Dec 19, 2019

Targeting the integrated stress response to treat Down syndrome

...an EIF2B activator that counters the effects of EIF2 phosphorylation, improved long-term memory. In 2015, Calico Life Sciences LLC...
...Patient samples; mice LICENSING STATUS: Patented by the University of California San Francisco; licensed to Calico Life Sciences LLC...
...email: costamat@bcm.edu CONTACT: Peter Walter, University of California San Francisco, San Francisco, Calif. email: peter@walterlab.ucsf.edu Claire Quang Calico Life Sciences LLC Baylor...
BioCentury | Aug 29, 2019
Preclinical News

Aug. 29 Preclinical Quick Takes: New targets for leukemia from Calico and stroke from Gero; predictors of checkpoint inhibitor response and more

...Calico finds new target for sensitizing leukemia to NK cells Calico Life Sciences LLC (South San Francisco, Calif.) showed...
...receptor 2; PFKFB3 - 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3; TREM2 - Triggering receptor expressed on myeloid cells 2 BioCentury Staff Calico Life Sciences LLC Fudan...
BioCentury | Jun 7, 2019
Emerging Company Profile

insitro: machine learning with designated data

...data science, cancer immunology, genomics and stem cell biology. Koller was chief computing officer at Calico Life Sciences LLC...
...Koller Patents: None Companies and Institutions Mentioned Atomwise Inc, San Francisco, Calif. BenevolentAI, London, U.K. Calico Life Sciences LLC...
BioCentury | Jun 6, 2019
Company News

Management tracks: Grail taps Juno founder Bishop as CEO; plus Clovis, OncoCyte, Calico

...president of the genetic science division for Thermo Fisher Scientific Inc. (NYSE:TMO). Age-related disease company Calico Life Sciences LLC...
BioCentury | Jun 5, 2019
Company News

Management tracks: Settleman to lead Pfizer cancer R&D; plus Roivant, LabCorp and more

...group head of oncology R&D, effective July 1. He was head of oncology research at Calico Life Sciences LLC...
BioCentury | May 6, 2019
Translation in Brief

Baby brain organoids link stress response to hypoxic encephalopathy

...inhibits the integrated stress response (ISR), a pathway whose signaling intersects with UPR. In 2015, Calico...
...implicated ISR in cognitive defects following traumatic brain injury, and a 2018 eLife paper from Calico...
...Inc. (NYSE:ABBV) reported that ISRIB could help treat vanishing white matter disease (VWMD). Sandi Wong, Staff Writer Calico...
BioCentury | Apr 16, 2019
Company News

With insitro deal, Gilead turns to machine learning to unlock new NASH targets

...to be predictive of clinical outcomes. Before founding insitro, Koller was chief computing officer at Calico Life Sciences LLC...
BioCentury | Jan 31, 2019
Company News

Management tracks: Calico, Apellis, Immutep

...II. Khakoo was VP and head of translational medicine, global development at Amgen Inc. (NASDAQ:AMGN). Calico...
BioCentury | Nov 9, 2018
Company News

AbbVie gains Parkinson’s pipeline from BioArctic

...to neurodegenerative compounds emerging from a multibillion collaboration with Calico Life Sciences LLC (South San Francisco, Calif.) (see "Calico...
BioCentury | Nov 2, 2018
Company News

AbbVie gains Parkinson’s pipeline from BioArctic

...to neurodegenerative compounds emerging from a multibillion collaboration with Calico Life Sciences LLC (South San Francisco, Calif.) (see "Calico...
Items per page:
1 - 10 of 54
BioCentury | Dec 19, 2019

Targeting the integrated stress response to treat Down syndrome

...an EIF2B activator that counters the effects of EIF2 phosphorylation, improved long-term memory. In 2015, Calico Life Sciences LLC...
...Patient samples; mice LICENSING STATUS: Patented by the University of California San Francisco; licensed to Calico Life Sciences LLC...
...email: costamat@bcm.edu CONTACT: Peter Walter, University of California San Francisco, San Francisco, Calif. email: peter@walterlab.ucsf.edu Claire Quang Calico Life Sciences LLC Baylor...
BioCentury | Aug 29, 2019
Preclinical News

Aug. 29 Preclinical Quick Takes: New targets for leukemia from Calico and stroke from Gero; predictors of checkpoint inhibitor response and more

...Calico finds new target for sensitizing leukemia to NK cells Calico Life Sciences LLC (South San Francisco, Calif.) showed...
...receptor 2; PFKFB3 - 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3; TREM2 - Triggering receptor expressed on myeloid cells 2 BioCentury Staff Calico Life Sciences LLC Fudan...
BioCentury | Jun 7, 2019
Emerging Company Profile

insitro: machine learning with designated data

...data science, cancer immunology, genomics and stem cell biology. Koller was chief computing officer at Calico Life Sciences LLC...
...Koller Patents: None Companies and Institutions Mentioned Atomwise Inc, San Francisco, Calif. BenevolentAI, London, U.K. Calico Life Sciences LLC...
BioCentury | Jun 6, 2019
Company News

Management tracks: Grail taps Juno founder Bishop as CEO; plus Clovis, OncoCyte, Calico

...president of the genetic science division for Thermo Fisher Scientific Inc. (NYSE:TMO). Age-related disease company Calico Life Sciences LLC...
BioCentury | Jun 5, 2019
Company News

Management tracks: Settleman to lead Pfizer cancer R&D; plus Roivant, LabCorp and more

...group head of oncology R&D, effective July 1. He was head of oncology research at Calico Life Sciences LLC...
BioCentury | May 6, 2019
Translation in Brief

Baby brain organoids link stress response to hypoxic encephalopathy

...inhibits the integrated stress response (ISR), a pathway whose signaling intersects with UPR. In 2015, Calico...
...implicated ISR in cognitive defects following traumatic brain injury, and a 2018 eLife paper from Calico...
...Inc. (NYSE:ABBV) reported that ISRIB could help treat vanishing white matter disease (VWMD). Sandi Wong, Staff Writer Calico...
BioCentury | Apr 16, 2019
Company News

With insitro deal, Gilead turns to machine learning to unlock new NASH targets

...to be predictive of clinical outcomes. Before founding insitro, Koller was chief computing officer at Calico Life Sciences LLC...
BioCentury | Jan 31, 2019
Company News

Management tracks: Calico, Apellis, Immutep

...II. Khakoo was VP and head of translational medicine, global development at Amgen Inc. (NASDAQ:AMGN). Calico...
BioCentury | Nov 9, 2018
Company News

AbbVie gains Parkinson’s pipeline from BioArctic

...to neurodegenerative compounds emerging from a multibillion collaboration with Calico Life Sciences LLC (South San Francisco, Calif.) (see "Calico...
BioCentury | Nov 2, 2018
Company News

AbbVie gains Parkinson’s pipeline from BioArctic

...to neurodegenerative compounds emerging from a multibillion collaboration with Calico Life Sciences LLC (South San Francisco, Calif.) (see "Calico...
Items per page:
1 - 10 of 54